Tevogen Inc. Warrant Share Price
NASDAQ: TVGNWTevogen Inc. Warrant Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Tevogen Inc. Warrant Share Price Chart
Tevogen Inc. Warrant Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $-8.08 | Revenue (TTM) -$2.27M | Return On Equity (TTM) 319.08% |
Profit Margin 1155.49% | Debt to Equity -0.86 | Quarterly Earnings Growth YoY 2.68% |
Tevogen Inc. Warrant Quarterly Profit & Loss
All figures in USD
Tevogen Inc. Warrant Annual Profit & Loss
All figures in USD
About Tevogen Inc. Warrant
Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients. It is also developing TVGN 920 for treating cervical cancer; TVGN 960 for treating oropharyngeal cancer; TVGN 601 for treating MS; and TVGN 930 for treating EBV-associated lymphomas. Tevogen Bio Holdings Inc. was formerly known as Tevogen Bio Inc. and changed its name to Tevogen Bio Holdings Inc. in February 2024. The company was founded in 2020 and is headquartered in Warren, New Jersey.
Tevogen Inc. Warrant Historical Returns
| Month | Open | Close | Change % |
|---|
TVGNW Share Price FAQs
What is Tevogen Inc. Warrant share price today?
What is the 52 week high and 52 week low of Tevogen Inc. Warrant stock?
What is TVGNW's net income for the last quarter?
Can I buy TVGNW shares in India?